Erscheint 4 Ausgaben pro Jahr
ISSN Druckformat: 0731-8898
ISSN Online: 2162-6537
Indexed in
KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma
ABSTRAKT
Lung cancer is the most frequent malignancy and the leading cause of cancer-related death worldwide; it is the second most common cancer, comprising 1.69 million deaths worldwide per year. Among these, 85% of lung cancers are non-small-cell lung carcinoma (NSCLC). Metastasis is common in NSCLC patients and are responsible for most deaths. Kang-Ai 1 (KAI1), a tumor metastasis suppressor gene also known as Cluster of Differentiation 82 (CD82), is a member of the membrane tetraspanin protein family, which are capable of inhibiting the metastatic process in NSCLC. KAI1/CD82 suppresses metastasis via multiple mechanisms regulating inhibition of cell motility, adhesion, fusion, and proliferation. KAI1 may attenuate signaling to shut down metastatic colonization through attenuation of epidermal growth factor receptor (EGFR) signaling and inhibition of the Wnt signaling pathways. In this review, we focus on the differential expression of KAI1/CD82, a tumor metastasis suppressor gene that can inhibit cancer invasion and cell metastasis during NSCLC. The differential expression of KAI1/CD82 could prove to be of novel therapeutic significance in treating malignant tumors and in reducing their metastatic potential.
-
Ma Guodong, Zhu Jiping, Liu Feng, Yang Yan, Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p, DNA and Cell Biology, 38, 2, 2019. Crossref
-
Cheng Ruirui, Lu Xinhua, Xu Chenyang, Zhang Furui, Zhang Guojun, SNHG11 contributes to NSCLC cell growth and migration by targeting miR-485-5p/BSG axis, Biomedicine & Pharmacotherapy, 128, 2020. Crossref
-
Li Guanghui, Zhao Chunsheng, Zhang Haining, Yu Jia, Sun Yang, Zhang Yingying, <p>Hsa_circ_0046263 Drives the Carcinogenesis and Metastasis of Non-Small Cell Lung Cancer Through the Promotion of NOVA2 by Absorbing Mir-940 as a Molecular Sponge</p>, Cancer Management and Research, Volume 12, 2020. Crossref
-
Zhou Yongchun, Shi Hutao, Du Yaqian, Zhao Guangqiang, Wang Xiaoxiong, Li Quan, Liu Junxi, Ye Lianhua, Shen Zhenghai, Guo Yinjin, Huang Yunchao, lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/SOX9 axis, Aging, 11, 18, 2019. Crossref
-
Yan Wei, Huang Jinny, Zhang Qian, Zhang Jian, Ahmad Nihal, Role of Metastasis Suppressor KAI1/CD82 in Different Cancers, Journal of Oncology, 2021, 2021. Crossref
-
Jiang Pan, Li Fan, Liu Zilong, Hao Shengyu, Gao Jian, Li Shanqun, BTB and CNC homology 1 (Bach1) induces lung cancer stem cell phenotypes by stimulating CD44 expression, Respiratory Research, 22, 1, 2021. Crossref
-
Viera Maximillian, Yip George Wai Cheong, Shen Han-Ming, Baeg Gyeong Hun, Bay Boon Huat, Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer, Cancers, 13, 17, 2021. Crossref
-
Li Yuxiao, Hou Wei, Study on the Effects of miR-490-3p on the Malignant Biological Behavior of Lung Tumor Cell A549 and Its Molecular Mechanism, Journal of Biomaterials and Tissue Engineering, 11, 6, 2021. Crossref
-
Dabravolski Siarhei A., Bezsonov Evgeny E., Baig Mirza S., Popkova Tatyana V., Nedosugova Ludmila V., Starodubova Antonina V., Orekhov Alexander N., Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk, International Journal of Molecular Sciences, 22, 9, 2021. Crossref
-
Xiao Dong, Dong Zhanjun, Zhen Linqing, Xia Guanggai, Huang Xinyu, Wang Tiezhong, Guo Huaibin, Yang Binhui, Xu Cheng, Wu Weiwei, Zhao Xiaoyu, Xu Hong, Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer, Molecular Cancer Research, 18, 2, 2020. Crossref
-
Xu Yufen, Yang Qi, Fang Zhixian, Tan Xiaoli, Zhang Ming, Chen Wenyu, Huang Tao, TRIM66 Promotes Malignant Progression of Non-Small-Cell Lung Cancer Cells via Targeting MMP9, Computational and Mathematical Methods in Medicine, 2022, 2022. Crossref
-
Yang Lifei, Salai Adili, Sun Xiaohong, Liu Qing, Liu Tao, Zhang Qiqi, Tuerxun Aerziguli, Tan Yiyi, Zheng Shutao, Lu Xiaomei, Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma, Journal of Proteomics, 265, 2022. Crossref
-
Liu Ying, Zhang Yong, Li Qiubo, Xu Ruiqi, Huang Nian, MiR ‐200c‐3p and miR ‐485‐5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non–small cell lung cancer cells through targeting RRM2 , Thoracic Cancer, 13, 13, 2022. Crossref